Literature DB >> 26483133

The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.

Branislav Veselý1, Angelo Antonini2, Ivan Rektor3.   

Abstract

White matter lesions (WML) associated with cerebrovascular disease (CVD) may be observed on magnetic resonance imaging in Parkinson's disease (PD) patients. WML are an important factor contributing to postural, gait, and cognitive impairment in the elderly without PD and worsening the course of Alzheimer's disease (AD). Numerous articles are available on this topic. Whether WML modify and negatively influence the clinical symptoms, and course of PD is a subject of debate. The aim of this review is to examine the available literature on the contribution of WML to PD motor symptoms in relation to clinical characteristics and methods of assessing WML on MRI. After reviewing the database, we identified 19 studies reporting the relationship between WML and PD; ten studies focusing on the impact of WML on the cognitive status in PD were excluded. We analysed altogether nine studies reporting the relationship between WML and motor signs of PD. The review found association between WML severity and freezing of gait, less significant to responsiveness to dopaminergic treatment and postural instability; no negative impact on tremor and falls was observed. The impact of WML on bradykinesia and rigidity was inconsistent. Comorbid WML is associated with worsening axial motor performance, probably independently from the degree of nigrostriatal dopaminergic denervation in PD. Reducing the vascular risk factors that cause WML may be helpful in preventing the development of axial symptoms and ultimately in improving the quality of life of patients with PD. Given the lack of systematic studies, additional research in this field is needed.

Entities:  

Keywords:  Cerebrovascular disease; Magnetic resonance imaging; Parkinson’s disease; White matter lesions

Mesh:

Year:  2015        PMID: 26483133     DOI: 10.1007/s00702-015-1470-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  101 in total

1.  Hemiparkinsonism with a discrete lacunar infarction in the contralateral substantia nigra.

Authors:  Kouichi Ohta; Katsuyuki Obara
Journal:  Mov Disord       Date:  2006-01       Impact factor: 10.338

2.  Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait.

Authors:  Brett W Fling; Rajal G Cohen; Martina Mancini; John G Nutt; Damian A Fair; Fay B Horak
Journal:  Brain       Date:  2013-07-03       Impact factor: 13.501

3.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

4.  Axial signs and magnetic resonance imaging correlates in Parkinson's disease.

Authors:  Hernish J Acharya; Thomas P Bouchard; Derek J Emery; Richard M Camicioli
Journal:  Can J Neurol Sci       Date:  2007-02       Impact factor: 2.104

5.  Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?

Authors:  F J Vingerhoets; M Schulzer; D B Calne; B J Snow
Journal:  Ann Neurol       Date:  1997-01       Impact factor: 10.422

6.  Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study.

Authors:  Sarah E Vermeer; Peter J Koudstaal; Matthijs Oudkerk; Albert Hofman; Monique M B Breteler
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

7.  Basal ganglia lacunes and parkinsonism.

Authors:  R Inzelberg; N M Bornstein; I Reider; A D Korczyn
Journal:  Neuroepidemiology       Date:  1994       Impact factor: 3.282

8.  Prevalence of stroke in Parkinson's disease: a postmortem study.

Authors:  Frank L Mastaglia; Russell D Johnsen; Byron A Kakulas
Journal:  Mov Disord       Date:  2002-07       Impact factor: 10.338

Review 9.  Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment.

Authors:  Gary A Rosenberg; Maria Bjerke; Anders Wallin
Journal:  Stroke       Date:  2014-04-01       Impact factor: 7.914

10.  Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.

Authors:  A Antonini; P Vontobel; M Psylla; I Günther; P R Maguire; J Missimer; K L Leenders
Journal:  Arch Neurol       Date:  1995-12
View more
  14 in total

1.  Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease.

Authors:  Tanja Stojkovic; Elka Stefanova; Ivan Soldatovic; Vladana Markovic; Iva Stankovic; Igor Petrovic; Federica Agosta; Sebastiano Galantucci; Massimo Filippi; Vladimir Kostic
Journal:  J Neurol       Date:  2018-03-23       Impact factor: 4.849

Review 2.  Aging of cerebral white matter.

Authors:  Huan Liu; Yuanyuan Yang; Yuguo Xia; Wen Zhu; Rehana K Leak; Zhishuo Wei; Jianyi Wang; Xiaoming Hu
Journal:  Ageing Res Rev       Date:  2016-11-16       Impact factor: 10.895

3.  Obstructive Sleep Apnea and Other Vascular Risk factors' Impact on Non-Motor Symptoms in Parkinson's Disease.

Authors:  Bruna Meira; Marco Fernandes; Manuel Salavisa; Marlene Saraiva; Laurete Conceição; Cláudia Borbinha; Filipa Ladeira; João Pedro Marto; Raquel Barbosa; Marcelo Mendonça; Paulo Bugalho
Journal:  Mov Disord Clin Pract       Date:  2022-07-06

4.  Association of homocysteine, folate, and white matter hyperintensities in Parkinson's patients with different motor phenotypes.

Authors:  Yuan Shen; Zhi-Feng Dong; Ping-Lei Pan; Gang Xu; Jun-Ying Huang; Chun-Feng Liu
Journal:  Neurol Sci       Date:  2019-05-04       Impact factor: 3.307

Review 5.  Therapy of Parkinson's Disease Subtypes.

Authors:  Connie Marras; K Ray Chaudhuri; Nataliya Titova; Tiago A Mestre
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

6.  Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.

Authors:  L M Chahine; C Dos Santos; M Fullard; C Scordia; D Weintraub; G Erus; L Rosenthal; C Davatzikos; C T McMillan
Journal:  Eur J Neurol       Date:  2018-10-28       Impact factor: 6.089

7.  Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease.

Authors:  Naveed Malek; Michael A Lawton; Diane M A Swallow; Katherine A Grosset; Sarah L Marrinan; Nin Bajaj; Roger A Barker; David J Burn; John Hardy; Huw R Morris; Nigel M Williams; Nicholas Wood; Yoav Ben-Shlomo; Donald G Grosset
Journal:  Mov Disord       Date:  2016-10       Impact factor: 10.338

8.  White matter alterations in Parkinson's disease with normal cognition precede grey matter atrophy.

Authors:  Ivan Rektor; Alena Svátková; Lubomir Vojtíšek; Iva Zikmundová; Jirí Vaníček; András Király; Nikoletta Szabó
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

9.  White Matter Changes-Related Gait and Executive Function Deficits: Associations with Age and Parkinson's Disease.

Authors:  Jennifer Sartor; Kristina Bettecken; Felix P Bernhard; Marc Hofmann; Till Gladow; Tobias Lindig; Meltem Ciliz; Mara Ten Kate; Johanna Geritz; Sebastian Heinzel; Marije Benedictus; Philip Scheltens; Markus A Hobert; Walter Maetzler
Journal:  Front Aging Neurosci       Date:  2017-06-30       Impact factor: 5.750

10.  Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts.

Authors:  Diane M A Swallow; Michael A Lawton; Katherine A Grosset; Naveed Malek; Johannes Klein; Fahd Baig; Claudio Ruffmann; Nin P Bajaj; Roger A Barker; Yoav Ben-Shlomo; David J Burn; Thomas Foltynie; Huw R Morris; Nigel Williams; Nicholas W Wood; Michele T M Hu; Donald G Grosset
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-09-26       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.